A comparison of surgery versus transcatheter angiographic embolization in the treatment of nonvariceal upper gastrointestinal bleeding uncontrolled by endoscopy
Authors:
- Daphne AngDADaphne Ang
- Eng Kiong TeoETEng Kiong Teo
- Andrew TanATAndrew Tan
- Salleh IbrahimSISalleh Ibrahim
- Poh Seng TanPTPoh Seng Tan
- Tiing Leong AngTATiing Leong Ang
- Kwong Ming FockKFKwong Ming Fock
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (8) , 929-938
Abstract
Patients with recurrent nonvariceal upper gastrointestinal bleeding who have failed endoscopic therapy pose a challenge. Percutaneous transcatheter angiographic embolization (TAE) is an alternative to surgery but remains controversial. This study compares the treatment outcomes in patients with recurrent nonvariceal upper gastrointestinal bleeding. A retrospective single-centre study of consecutive patients who underwent TAE (January 2007-December 2010) compared with patients treated surgically (January 2004-December 2010) was conducted. Patient demographics, comorbidities, rebleeding rates, length of stay and mortality were compared. Thirty [23 men; age (SD) 66.5±15.6 years] and 63 [41 men; age (SD) 68.2±15.0 years, NS] patients underwent TAE and surgery after a mean (SD) of 1.7±1.0 and 2.1±1.1 (NS) gastroscopies, respectively, for gastric ulcers (n=28), duodenal ulcers (n=53), small-bowel diverticuli (n=7), jejunal ulcer (n=1) and gastric Dieulafoy's lesions (n=2). Ten (33.3%) and 44 (69.8%) patients who underwent TAE and surgery, respectively, had an American Society of Anesthesiologists status of at least 2 (P=0.001). Higher rebleeding rates were observed after TAE compared with surgery [n=14 (46.7%) vs. 8 (12.7%), P=0.001]; however, there were no significant differences in 30-day mortality (16.7 vs. 19.0%, NS), complication rates (46.7 vs. 60.3%, NS) and length of stay (45.1±9.8 vs. 25.5±18.1 days, P=0.06). Twenty-four out of 30 patients (80%) who underwent TAE achieved haemostasis after a median (SD) of 2.0 (1.2) TAE procedures. Rebleeding occurred in five out of seven patients (71%) who underwent TAE for small-bowel diverticular bleeding. TAE averted the need for surgery in high-risk patients. Its role in low surgical risk patients or patients with small-bowel diverticular bleeding requires further study.Keywords
This publication has 28 references indexed in Scilit:
- International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal BleedingAnnals of Internal Medicine, 2010
- Embolization as Treatment of Choice for Bleeding Peptic Ulcers in High-Risk PatientsDigestive Surgery, 2009
- Short- and Long-Term Results of Transcatheter Embolization for Massive Arterial Hemorrhage from Gastroduodenal Ulcers Not Controlled by Endoscopic HemostasisCanadian Journal of Gastroenterology and Hepatology, 2009
- Transcatheter arterial embolization in patients with bleeding duodenal ulcer: an alternative to surgeryActa Radiologica, 2006
- Ulcère gastroduodénal hémorragique : résultats du traitement chirurgicalAnnales de Chirurgie, 2001
- Arterial Embolotherapy for Upper Gastrointestinal Hemorrhage: Outcome AssessmentJournal of Vascular and Interventional Radiology, 2001
- Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United KingdomBMJ, 1995
- Bleeding Peptic UlcerNew England Journal of Medicine, 1994
- Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysisGastroenterology, 1992
- Selective Arterial EmbolizationRadiology, 1972